Nadia Ahmad
Company: Eli Lilly & Co.
Job title: Associate Vice President
Seminars:
Panel Discussion & Extended Q&A: Exploring Standardization, the Alignment of Endpoints with Regulatory Standards, & Avoiding Weight Cycling with New Obesity Treatments 11:15 am
day: Conference Day Two
Unveiling Trial Related Considerations For Late-Stage Development Of Incretin-Based Therapies 9:00 am
Leveraging experience in the field and with phase 3 incretin trials at Lilly to explore latestage obesity drug development Investigating patient safety in trials which are driving the standard of care Driving forward innovation in obesity trialsRead more
day: Conference Day Two